Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy

Du, Hongqing, Cline, Melissa S, Osborne, Robert J, Tuttle, Daniel L, Clark, Tyson A, Donohue, John Paul, Hall, Megan P, Shiue, Lily, Swanson, Maurice S, Thornton, Charles A, Ares, Manuel·2010·Nature Structural & Molecular Biology
DOI 10.1038/nsmb.1720

Cited by (331)

Items 301–331 of 331

  1. SURVEY AND SUMMARY Molecular mechanisms in DM1 – – a focus on foci
    Olof Joakim Pettersson, Lars Aagaard, Thomas Gryesten Jensen, Kroun Damgaard · 2014
  2. Auto-regulation of the MBNL1 pre-mRNA
    Devika P. Gates · 2011 · Scholars' Bank (University of Oregon)
  3. SPLICING ABNORMALITIES IN MYOTONIC DYSTROPHIES
    Denis Furling · 2014 · Istituto Lombardo - Accademia di Scienze e Lettere - Incontri di Studio
  4. Structure-stabilizing rna modifications prevent mbnl binding to toxic CUG and CCUG repeat RNA in myotonic dystrophy
    Elaine deLorimier · 2015 · Scholars' Bank (University of Oregon)
  5. Analysis and Modulation of PACT, DICER and MBNL1 in the Context of Myotonic Dystrophy Type I
    Mehrdad Azimi · 2016 · uO Research (University of Ottawa)
  6. RNAi Screening of the Kinome Identifies PACT as a Novel Genetic Modifier of Foci Integrity in Myotonic Dystrophy type 1
    Sean O’Reilly · 2014 · uO Research (University of Ottawa)
  7. Clinical Features of Skeletal Muscle and Their Underlying Molecular Mechanism
    Masanori P. Takahashi · 2018 · Springer eBooks
  8. Molecular Defects in the DM Central Nervous System
    Takashi Kimura · 2018 · Springer eBooks
  9. Functional impact of alternative splicing in vertebrate proteomes across tissues and cell types
    Tapial Rodríguez, Javier Javier · 2018 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  10. RNA toxicity in tandem nucleotide repeats mediated neurodegenerative disorders
    Nishu Tyagi, Uzma Shamim, Mohammed Faruq · 2020 · Elsevier eBooks
  11. Altered drug metabolism and increased susceptibility to fatty liver disease in myotonic dystrophy
    Zachary Dewald, Andrew S. Gupta, Ullas Valiya Chembazhi, Auinash Kalsotra · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  12. MBNL1 and RBFOX1 co-regulate alternative splicing events transcriptome-wide through a conserved buffering mechanism
    Melissa A. Hale, Joseph Ellis, Ryan C. Meng, Sunny McDaniel, Amy E. Mahady, Stacey D. Wagner, Jared I. Richardson, Ona L. McConnell, Eric T. Wang, J. Andrew Berglund · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  13. RNA nucleotide repeats induce mitochondrial dysfunction and the ribosome-associated quality control
    Joana Teixeira, Anu-Mari Harju, Alaa Othman, Ove Eriksson, Ana S. Brandão, Brendan James Battersby, Susana M. D. A. Garcia · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  14. Cpy(a/t)(q/w)e D-Hexapeptides Bind CUG Repeats and Rescue Phenotypes of Myotonic Dystrophy Myoblasts and A Drosophila Model of the Disease
    Ariadna Bargiela, Ruben D. Artero, Roger Estrada‐Tejedor, Anna Serafina Rapisarda, Enrique García‐España, Beatriz Llamusí, Manuel Pérez‐Alonso, Isabel Pont · 2020 · Research Square
  15. Musleblind-1 regulates microtubule cytoskeleton in C. elegans mechanosensory neuron through tubulin mRNAs
    Dharmendra Puri, Sarbani Samaddar, Sourav Banerjee, Anindya Ghosh‐Roy · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Competition for the conserved branch point sequence influences physiological outcomes in pre-mRNA splicing
    Karen Larissa Pereira de Castro, Jose M Abril, Kuo‐Chieh Liao, Haiping Hao, John Paul Donohue, William K. Russell, William Samuel Fagg · 2024 · eLife
  17. An ancient competition for the conserved branchpoint sequence influences physiological and evolutionary outcomes in splicing
    Karen Larissa Pereira de Castro, Jose M Abril, Kuo‐Chieh Liao, Haiping Hao, John Paul Donohue, William K. Russell, William Samuel Fagg · 2024 · eLife
  18. Transcriptome-wide isoform and promoter remodeling in DM1 fibroblasts uncovered by long-read RNA sequencing
    Xinbo Ji, Ruiyan Zhang, Didi Shan, Tongwei Shi, Yingxin Wang, Yao Tang, Zexin Zhan, Yichang Jiao, Hongxu Wang, Jianing Li et al. · 2025 · Genomics
  19. A pothole-filling strategy for selective targeting of rCUG-repeats associated with myotonic dystrophy type 1
    J. Dinithi R. Perera, Shivaji A. Thadke, Savani W. Thrikawala, Isha Dhami, V. M. Hridya, Arnab Mukherjee, Ananya Paul, W. David Wilson, Keith W. R. Tan, Nicholas Z. W. Chan et al. · 2026 · Proceedings of the National Academy of Sciences
  20. Uncovering molecular signatures and pathogenic pathways in myotonic dystrophy type 1 through bioinformatic analysis
    Ali Asghar Mahmoudi, Sercan Karav, Prashant Kesharwani, Amirhossein Sahebkar · 2026 · Human Gene
  21. Modélisation pathologique des maladies monogéniques par l'utilisation des cellules souches embryonnaires humaines : preuve de concept appliquée à la dystrophie myotonique de type 1
    Jérôme Alexandre Denis · 2010 · theses.fr (ABES)
  22. Une nouvelle fonction pour la DEAD-box ARN hélicase p68/DDX5 dans la Dystrophie Myotonique de type 1
    François-Xavier Laurent · 2011 · theses.fr (ABES)
  23. Etude des mécanismes moléculaires et cellulaires impliqués dans le développement de la dystrophie myotonique de type 1 à l'aide de cellules souches embryonnaires humaines porteuses de la mutation causale
    Antoine Marteyn · 2010 · theses.fr (ABES)
  24. MBNL derivatives for therapeutic application in myotonic dystrophy
    Magdalena Matłoka · 2019 · theses.fr (ABES)
  25. Étude de la fonction des protéines MBNL au cours du développement à l’aide de cellules souches humaines induites à la pluripotence
    Antoine Mérien · 2021 · theses.fr (ABES)
  26. Role of the immune receptor CD47 in mouse model of non-infectious uveitis
    Yueshen Che · 2026 · theses.fr (ABES)
  27. Elimination of myotonia improves myopathy in a muscleblind-like knockout model of myotonic dystrophy
    Matthew T. Sipple, Sakura A. Hamazaki, Vanessa Todorow, Lily A. Cisco, Katherine M Lupia, Christina S. Heil, Peter Meinke, Charles A. Thornton, John D. Lueck · 2026 · Nature Communications
  28. A bitter melon natural compound ameliorates the myotonic dystrophy type 1 skeletal muscle phenotype in a sex-specific manner
    Shatha A. Atieh, Chimène Fahmi, Jia Liu, Chunping Tang, Yang Ye, Aymeric Ravel‐Chapuis, Bernard Jean Jasmin · 2026 · Neurotherapeutics
  29. Alternative splicing dysregulation in CAG repeat expansion diseases
    Asmer Aliyeva, John D. Cleary, Hannah K. Shorrock, J. Andrew Berglund · 2026 · Trends in Neurosciences
  30. BmMBNL Knockout Disrupts Molting of Silkworm, Bombyx mori, Through Inhibiting Expressions of Chitin Synthetase and Chitinase
    Huan Dong, Zihan Meng, Mengyao He, Yujuan Zhou, Ding Tu, He Wang, Xian Li, Yiwen Liang, Wenjuan Fan, Chaopin Zhu et al. · 2026 · Insects
  31. Dynamic NFIX Promoter Usage Shapes Stem and Committed Myogenic States
    Gabriele Rovetta, Giulia Ferrari, Mirko Ronzio, Alberto Gallo, Raffaele Epis, Chiara Bonfanti, Diletta Dolfini, Giorgia Careccia, Graziella Messina · 2026 · International Journal of Molecular Sciences